Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
04/2010
04/20/2010CA2348741C Nitrosasted and nitrosylated nonsteroidal antiinflammatory compounds, comositions and methods of use
04/15/2010WO2010042626A1 1-phenylpyrrole compounds
04/15/2010WO2010042622A1 Atropisomers of (hydroxyalkyl) pyrrole derivatives
04/15/2010WO2010042030A1 Aspartyl protease inhibitors
04/15/2010WO2010041964A1 Methods for the preparation of alkenylamines, cyclic carbamates or dithiocarbamates, and aminoalcohols or aminothiols
04/15/2010WO2010041748A1 Fluorene compound and use thereof for medical purposes
04/15/2010WO2010041402A1 Method for producing tetrafluoro compound
04/15/2010WO2010040881A1 Aryl and heteroaryl derivatives of 2,2'-bipyrroles and preparation procedure
04/15/2010WO2010040663A1 Pyrrolidine n-benzyl derivatives
04/15/2010WO2010022033A3 Therapeutic substituted pyrroles
04/15/2010US20100094003 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases
04/15/2010US20100093855 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia
04/15/2010US20100093826 Atropisomer of pyrrole derivative
04/15/2010US20100093825 Bicycloester derivative
04/15/2010US20100093733 Amide and urea derivatives for the treatment of metabolic diseases
04/15/2010CA2738870A1 Pyrrolidine n-benzyl derivatives
04/15/2010CA2736930A1 1-phenylpyrrole compounds
04/15/2010CA2736923A1 Atropisomers of (hydroxyalkyl) pyrrole derivatives
04/14/2010EP2173711A1 Phenoxy-pyrrolidine derivative and its use and compositions
04/14/2010EP2173710A1 Novel crystalline form
04/14/2010EP2173709A2 Methods and intermediates for synthesis of selective dpp-iv inhibitors
04/14/2010EP2173707A1 Pleuromutilin derivatives and their use as antimicrobials
04/14/2010EP1858890B1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
04/14/2010EP1694410B1 Cyclopropane derivatives and pharmaceutical use thereof
04/14/2010EP1551799B1 Cyclohexyl sulphones as gamma-secretase inhibitors
04/14/2010EP1335901B1 Pharmaceutically active sulfanilide derivatives
04/14/2010CN101694867A Organic light emitting devices having carrier blocking layers comprising metal complexes
04/14/2010CN101693708A Azasugar compound containing aryl and preparation process and application thereof
04/14/2010CN101693685A Method for preparing 4-hydroxylethylpyrrolidone-2-acetamide
04/14/2010CN101693684A Method for preparing 4-hydroxylethylpyrrolidone-2-acetamide
04/14/2010CN101693200A Catalyst for synthesizing glimepiride key intermediate and synthesizing method thereof
04/13/2010US7696359 Compound modified with glycerol derivative
04/13/2010US7696358 Five-membered heterocyclyl tetracycline compounds and methods of use thereof
04/13/2010US7696357 Darifenacin solvate with toluene; mixing the free base with toluene to form the solvate, converting to the hydrate, addition salt formation with hydrogen bromide; high purity, extended shelf life; irritable bowel syndrome, incontinence and other gastrointestinal disorders
04/13/2010US7696243 Pyrrolidin-2-one derivatives for use as DP1 receptor agonists
04/13/2010US7696242 inhibitors of the hepatitis C virus NS3 protease; azalactone intermediate reacted with cycloalkylsulfonamide and decylization; urea or carbamate-terminated alkylglycine, hydroxyproline, cyclopropylglycine tripeptide
04/13/2010US7696234 Histamine H3 receptor agents, preparation and therapeutic uses
04/13/2010US7696198 Phosphodiesterase 4 inhibitors
04/13/2010CA2436220C New mandelic acid derivatives and their use as thrombin inhibitors
04/13/2010CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/08/2010WO2010039947A1 Novel compounds as calcium channel blockers
04/08/2010WO2010039793A1 Hepatitis c virus inhibitors
04/08/2010WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
04/08/2010WO2010039124A1 Benzenesulfonic acid salt compounds
04/08/2010WO2010038434A1 Process for production of optically active hexahydropyrroloquinoline and intermediate for the process
04/08/2010WO2010037760A1 Compounds which potentiate ampa receptor and uses thereof in medicine
04/08/2010WO2010037207A1 Selective glycosidase inhibitors and uses thereof
04/08/2010WO2010018926A3 Method for preparing n-substituted maleimides
04/08/2010WO2010007248A3 Novel tricyclic derivatives, process for the preparation thereof and pharmaceutical compositions containing same
04/08/2010WO2009053763A8 New non-peptide derivatives as bradykinin b1 antagonists
04/08/2010US20100087658 Methods and intermediates for synthesis of selective dpp-iv inhibitors
04/08/2010US20100087651 New mandelic acid derivatives and their use as thrombin inhibitors
04/08/2010US20100087634 Fluorous Oligonucleotide Reagents and Affinity Purification of Oligonucleotides
04/08/2010US20100087506 Cyclic amine compound
04/08/2010US20100087466 Novel small molecule dnak inhibitors
04/08/2010US20100087442 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
04/08/2010US20100087432 Pyrrole derivatives having crth2 receptor antagonist activity
04/08/2010US20100087427 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin
04/08/2010US20100087320 Arylphenyl-substituted cyclic keto-enols
04/08/2010CA2738768A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
04/08/2010CA2737480A1 Novel compounds as calcium channel blockers
04/08/2010CA2737267A1 Selective glycosidase inhibitors and uses thereof
04/07/2010EP2172559A1 Screening method
04/07/2010EP2172463A1 Quaternary ammonium salt, electrolytic solution and electrochemical device
04/07/2010EP2172452A1 Preparation of crystalline atorvastatin magnesium
04/07/2010EP2172451A2 Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis and use thereof
04/07/2010EP2170916A1 Furanose derivatives
04/07/2010EP2170822A2 Proton acceptor iminium/carbocation-type coupling agents
04/07/2010EP2170821A1 Method for preparing fmoc-based hydrolysable linkers
04/07/2010EP2170820A2 Improved process of amide formation
04/07/2010EP2170076A1 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
04/07/2010CN101691507A Diesel pour point depressant and preparation method thereof
04/06/2010US7692034 Process for the preparation of 7-amino syn 3,5-dihydroxy heptanoic acid derivatives via 6-cyano syn 3,5-dihydroxy hexanoic acid derivatives
04/06/2010US7692028 for treating neurological disorders such as epilepsy, neuropathic pain, bipolar disorder or migraine; 2-(2-oxo-4-propyl-1-pyrrolidinyl)butanamide; neuroprotective agent
04/06/2010US7692019 for treatment of drug addiction and pain; isomerization catalysts; combinatorial chemistry
04/06/2010US7691897 Therapeutic agent
04/06/2010US7691843 Inhibitors of UPD-3-O (R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase, an enzyme present in gram negative bacteria; azetidine, pyrrolidine, or 3-pyrroline 2-carboxylic acid hydroxyamides; 1-(3,4-dimethoxy-5-propylbenzoyl)pyrrolidine-2R-carboxylic acid hydroxyamide for example
04/06/2010US7691837 e.g. 1-{[1,5-bis(4-cholorophenyl)-2-methylpyrrol-3-yl]methyl}-4-(4-fluoro-phenyl)piperazine; Mycobacterium tuberculosis, drug resistant Mycobacterium tuberculosis, Mycobacterium avium-intracellulare complex, Mycobacterium fortuitum or Mycobacterium kansasi
04/06/2010US7691818 Identified new isostere of the dipeptide phenylalanine-proline (Phe-Pro) having four stereogenic centers on which compounds are based; enzyme inhibitors; viricides; HIV; post-exposure prophylaxis and as infection therapy
04/06/2010CA2566108C Proline derivatives and their use as dipeptidyl peptidase iv inhibitors
04/06/2010CA2530814C Quaternary ammonium salt, electrolyte, and electrochemical device
04/06/2010CA2252536C Ethylene derivatives and pesticides containing said derivatives
04/01/2010WO2010036814A1 Selective seprase inhibitors
04/01/2010WO2010035727A1 Novel pyrrolinone derivative and medicinal composition containing same
04/01/2010WO2010034118A1 Nitric oxide releasing amino acid ester compound, composition and method of use
04/01/2010WO2009131669A3 Carbamate and urea inhibitors of 11beta-hydroxysteroid dehydrogenase 1
04/01/2010US20100081830 Methods of synthesizing n-hydroxysuccinimidyl carbonates
04/01/2010US20100081826 7-pyrrolyl tetracycline compounds and methods of use thereof
04/01/2010US20100081806 Method of producing highly functionalized 1,3-diamino-propan-2-ols from solid support
04/01/2010US20100081702 Pharmaceutical composition for prophylaxis or treatment of hepatitis
04/01/2010US20100081701 FAP inhibitors
04/01/2010DE102008049767A1 N-geschützte Guanidin-substituierte Furane, Thiophene und Pyrrole als Cystein-Protease-Inhibitoren N-protected guanidine-substituted furans, thiophenes and pyrroles as cysteine ​​protease inhibitors
04/01/2010CA2775370A1 Nitric oxide releasing amino acid ester compound, composition and method of use
04/01/2010CA2737941A1 Selective seprase inhibitors
03/2010
03/31/2010EP2167619A2 Pyrrolidine-2,5-dione derivatives for use in friction modification
03/31/2010EP1807393B1 Diarylsulfones as 5-ht2a antagonists
03/31/2010EP1678132B1 Process for the production of lactams
03/31/2010EP1620091B1 Inhibitors of glutaminyl cyclase
03/31/2010EP1252139B1 Trifluoromethylpyrrole carboxamides and trifluoromethylpyrrolethioamides as fungicides
03/31/2010CN101687913A kallikrein 7 modulators
1 ... 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 ... 404